Purchase Order 75N92025P00349
Award Date
8/29/25
Potential Completion Date
8/28/26
Potential Value
$25K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Piscataway, NJ 08854, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, was made by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). The contract, valued at $24,999.00, is for gene synthesis, sub-cloning, and plasmid preparation services to support NHLBI's PRAT IRTA Fellowship program, which is investigating the evolution of the protein RFAH. The contract is a firm-fixed price purchase order and does...
This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company, for custom gene synthesis services. The contract has a potential value of $21,275.80 and a completion date of August 19, 2020. Genscript, based in Piscataway, New Jersey, specializes in gene synthesis, gene editing, custom protein and...
This is a firm fixed price purchase order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc., a for-profit biotechnology company. The $156,465.00 contract is for gene synthesis and protein production services to support ongoing biomedical research and public health initiatives. It is a follow-on service from a previous award and the agency determined that Genscript is the only responsible source that can...
This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $15,289.00 contract will run through September 30, 2024 and does not have a set-aside designation. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services that support...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $19,316.68 firm fixed price purchase order to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom plasmid preparation services to support biomedical research and public health initiatives. Genscript has extensive experience providing specialized products and services to federal...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Genscript USA Inc. for $249,943.63 to provide DNA synthesis, plasmid, and protein production services. The contract supports ongoing research projects at the NIAID Vaccine Research Center and was awarded on a sole-source basis as Genscript was determined to be the only source capable of meeting the salient requirements. The award does not...
This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...